We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Alpha-GPC and Vinpocetine are closely matched across evidence, studies, and safety.
Verdict
Likely helps
6 of 6 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
6 of 6 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (2)
Outcomes where both Alpha-GPC and Vinpocetine have evidence — compare verdict strength side-by-side.
300-600mg daily
Morning for cognitive enhancement, 30-60 min before workout for performance
Alpha-GPC 50% powder or capsules
10-30mg daily in divided doses
With food (improves absorption), Divided into 2-3 doses, Morning and early afternoon
Vinpocetine capsules or tablets
1-2 hours
2-4 weeks
Acute
Same day
2-4 weeks
1-2 weeks
2-4 weeks
First few days
L-Alpha-Glycerylphosphorylcholine (L-α-GPC): A Comprehensive Review of Its Preparation Techniques and Versatile Biological Effects
Journal of food science (2025) · Systematic review
Due to its high choline content (41% by weight) and ability to cross the blood-brain barrier, GPC is considered one of the most utilized sources of choline.
Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis
Journal of Alzheimer's disease : JAD (2023) · Meta analysis · n=1326
We found significant effects of α-GPC in combination with donepezil on cognition [4 RCTs, mean difference (MD):1.72, 95% confidence interval (CI): 0.20 to 3.25], functional outcomes [3 RCTs, MD:0.79, 95% CI: 0.34 to 1.23], and behavioral outcomes [4 RCTs; MD: -7.61, 95% CI: -10.31 to -4.91].
Revisiting choline alphoscerate profile: a new, perspective, role in dementia?
The International journal of neuroscience (2013) · Systematic review
Choline alphoscerate (alpha-glyceryl-phosphorylcholine, alpha-GPC) is a semisynthetic derivative of phosphatidylcholine with central parasympathomimetic action.
Efficacy and safety of herbal medicine on dementia and cognitive function: An umbrella review of systematic reviews and meta-analysis
Phytotherapy research : PTR (2023) · Meta analysis
Of these, 65% were rated critically low using AMSTAR2.
Neuroprotective Phytochemicals in Experimental Ischemic Stroke: Mechanisms and Potential Clinical Applications
Oxidative medicine and cellular longevity (2021) · Systematic review
Among them, scutellarin, pinocembrin, puerarin, hydroxysafflor yellow A, salvianolic acids, rosmarinic acid, borneol, bilobalide, ginkgolides, ginsenoside Rd, and vinpocetine show great potential in clinical ischemic stroke treatment.
The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis
Psychopharmacology (2018) · Meta analysis · n=44854
The pooled standardized mean difference of the treatment effects on cognitive dysfunction was 0.439 (95% confidence interval 0.374, 0.504).
Based on RCTs showing cognitive improvements in healthy adults and dementia patients. Effect sizes were modest and some studies used combination therapy. Higher doses associated with increased headache risk.
Based on stroke recovery and dementia studies. CAVIN trial (n=469) showed significant cognitive improvements. Meta-analysis found modest effect size (0.439 SMD). Limited data in healthy populations. Most evidence from clinical populations with cerebrovascular issues.
AI-estimated from published studies. Interpret as directional guidance.
Both Alpha-GPC and Vinpocetine are closely matched — the best choice depends on your specific health goals.
For sharpen focus, Alpha-GPC has a higher relevance score (80 vs 70).
No known interactions between Alpha-GPC and Vinpocetine have been documented in our database. However, always consult a healthcare provider before combining supplements.